Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Web-Based CAD System for Synthetic Biology Designs DNA Sequences in Minutes

By LabMedica International staff writers
Posted on 24 Sep 2009
A web-based computer-assisted design (CAD) environment for synthetic biology is under development, and after completion of the design process, the sequence can be downloaded for synthesis or further analysis. More...
Users who elect to create a personal account on the system can customize their workspace by creating their own parts libraries, adding new parts to the libraries, or reusing designs to quickly generate sets of related constructs.

The U.S. National Science Foundation (NSF; Arlington, VA, USA) has awarded a three-year US$1.4 million grant to Dr. Jean Peccoud, associate professor at the Virginia Bioinformatics Institute (VBI) at Virginia Polytechnic Institute and State University (Virginia Tech; Blacksburg, VA, USA), to develop the GenoCAD application.

Synthetic biology, a rapidly emerging area of biologic research, applies methods developed in engineering to design artificial biologic systems that meet user-defined specifications. It has also been used to redesign natural systems to better understand the fundamental characteristics of living organisms. "We are considering DNA as a language to program living organisms instead of computers," said Dr. Peccoud. "This analogy has led us to apply methods and results from computer science to biology. In particular, rules describing how different functional elements should be combined can be described in the language grammar."

The GenoCAD point-and-click user interface guides the user through the process of designing new sequences. By successively clicking on icons representing structural features or functional blocks, complex DNA sequences composed of dozens of functional blocks can be designed in a matter of minutes. "The development of GenoCAD will be a community-driven project," said Dr. Peccoud. "We intend to involve the synthetic biology research community in helping to advance this project in such a way that it meets the needs of a wide user base." The use of the public version of GenoCAD is free to anyone, while the open source distribution of the software makes it possible for research groups to install GenoCAD on their own servers and, if required, customize it to meet specific needs.

Early applications for GenoCAD include the development of vaccines, sensing devices for biodefense, and metabolic pathways for biofuel production.

The Virginia Bioinformatics Institute at Virginia Tech has a research platform based on understanding the "disease triangle" of host-pathogen-environment interactions in plants, humans, and other animals.

Related Links:

Virginia Bioinformatics Institute at Virginia Tech




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.